Johnson & Johnson (LON:0R34)

London flag London · Delayed Price · Currency is GBP · Price in USD
163.50
+1.70 (1.05%)
At close: Mar 27, 2025
10.47%
Market Cap 304.75B
Revenue (ttm) 70.55B
Net Income (ttm) 11.17B
Shares Out n/a
EPS (ttm) 4.60
PE Ratio 27.28
Forward PE n/a
Dividend 3.88 (2.38%)
Ex-Dividend Date Feb 18, 2025
Volume 3,696
Average Volume 19,715
Open 161.77
Previous Close 161.80
Day's Range 161.32 - 164.01
52-Week Range 143.14 - 165.71
Beta n/a
RSI 56.71
Earnings Date Apr 15, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R34
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.